On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
66° Feels Like: 66°
Wind: SW 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 44°

Tomorrow

Sunny 72°

Tues Night

Partly Cloudy 47°

Alerts

Breaking News

BREAKING NEWS / UPDATE: Wausau police confirm Stephanie Low's body was found in Wabeno; person of interest Kristopher Torgerson to be charged with homicide

WAUSAU, Wis (WSAU)  Wausau police say Stephanie Low's body has been found. Police revealed at a news conference today that a person of interest in her death, Kristopher Torgerson, led police to her body on September 19th. The body has since been positively ID'ed by the state crime lab. The autopsy lists 'homicide' as the cause of death. Torgerson had been questioned nearly four years ago after she had first disappeared. Wausau PD say he was in custody on other charges, and agreed to sh...

Read More »

Goldman sells final stake in former independent-research partner

A Goldman Sachs sign is seen over their kiosk on the floor of the New York Stock Exchange, April 26, 2010. REUTERS/Brendan McDermid
A Goldman Sachs sign is seen over their kiosk on the floor of the New York Stock Exchange, April 26, 2010. REUTERS/Brendan McDermid

By Lauren Tara LaCapra

NEW YORK (Reuters) - Goldman Sachs Group Inc received $32.5 million for its remaining stake in Epocrates Inc, after the healthcare technology company was acquired by athenahealth Inc , according to a securities filing on Friday.

Goldman had originally acquired 3 million shares in Epocrates for $40 million in 2007, as part of its plan to build out an independent-research arm called Hudson Street. The business sold institutional investors information from a variety of firms that collected data and performed market analysis.

Goldman acquired stakes in its Hudson Street partners as a bet that investor demand for independent research would rise. But the bank eventually dismantled the business because big trading clients were less interested in paying for the research than Goldman had predicted.

Epocrates was Goldman's last remaining investment related to the Hudson Street business. The bank cashed in 2.8 million shares for $11.75 apiece, according to terms of athenahealth's buyout. Goldman had also sold $4 million worth of stock when Epocrates went public in January 2011, bringing its total stock sales to $36.5 million.

(Reporting by Lauren Tara LaCapra; Editing by Richard Chang)

Comments